Treatment of chronic Hepatitis B in resource-constrained countries: An economic solution is required

Journal of Viral Hepatitis

Volumn 20, Issue SUPPL.1, 2013, Pages 2-

  Thomas, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; HEPATITIS B(E) ANTIGEN; PEGINTERFERON; TENOFOVIR;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG EFFICACY; EDITORIAL; HEALTH CARE COST; HEPATITIS B; HUMAN; PRIORITY JOURNAL; RISK REDUCTION;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEALTH RESOURCES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS;

EID: 84874630976     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12057     Document Type: Editorial

References (1)

1. Wiersma ST, McMahon B, Pawlotsky JM,. et al. Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int 2011; 31 (6): 755-761.